Review



prime scripttm ii reverse transcriptase  (Vazyme Biotech Co)


Bioz Verified Symbol Vazyme Biotech Co is a verified supplier
Bioz Manufacturer Symbol Vazyme Biotech Co manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Vazyme Biotech Co prime scripttm ii reverse transcriptase
    Prime Scripttm Ii Reverse Transcriptase, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 10522 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/transcriptase+prime+scripttm+rt/HiScript+III+RT+SuperMix+for+qPCR+%2BgDNA+wiper/pm37768308-61-16-21
    Average 99 stars, based on 10522 article reviews
    prime scripttm ii reverse transcriptase - by Bioz Stars, 2026-10
    99/100 stars

    Images

    Related Articles

    Transfection:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Expressing:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Oligomer Restriction:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Quantitative RT-PCR:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Real-time Polymerase Chain Reaction:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    SYBR Green Assay:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Extraction:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    RNA Extraction:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Reverse Transcription:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Gene Expression:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Spectrophotometry:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Concentration Assay:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    cDNA Synthesis:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Isolation:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Staining:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Nitric Oxide Assay:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Sampling:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Polymerase Chain Reaction:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Amplification:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Synthesized:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Agarose Gel Electrophoresis:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Electrophoresis:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master

    Nucleic Acid Electrophoresis:

    Article Title: Mrpl50 integrates glucolipotoxicity with hypoxia-inducible factor 1 alpha signaling to drive diabetic kidney disease
    Article Snippet: 48 h of stimulation with high glucose or palmitate, the expression of inflammatory factors was analyzed. A total RNA extraction kit was utilized for the extraction of total RNA from the cells/tissues (Vazyme, RC112-01). Subsequently, complementary DNA was prepared in accordance with the manufacturer's instructions (Vazyme, R323-01). RT-qPCR was tested on the machine using the qPCR SYBR Green Master



    Similar Products

    99
    TaKaRa transcriptase prime scripttm rt
    Transcriptase Prime Scripttm Rt, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/transcriptase+prime+scripttm+rt/PrimeScript+RT+Master+Mix/pm41828407-252-18-22
    Average 99 stars, based on 1 article reviews
    transcriptase prime scripttm rt - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    Vazyme Biotech Co prime scripttm ii reverse transcriptase
    Prime Scripttm Ii Reverse Transcriptase, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/transcriptase+prime+scripttm+rt/HiScript+III+RT+SuperMix+for+qPCR+%2BgDNA+wiper/pm37768308-61-16-21
    Average 99 stars, based on 1 article reviews
    prime scripttm ii reverse transcriptase - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    TaKaRa prime scripttm reverse transcriptase reagent kit
    Prime Scripttm Reverse Transcriptase Reagent Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/transcriptase+prime+scripttm+rt/PrimeScript+RT+Reagent+Kit/pmc04322730-66-8-14
    Average 99 stars, based on 1 article reviews
    prime scripttm reverse transcriptase reagent kit - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    Image Search Results